Literature DB >> 17413050

Increased risk of childhood asthma from antibiotic use in early life.

Anita L Kozyrskyj1, Pierre Ernst, Allan B Becker.   

Abstract

BACKGROUND: To address the major methodological issues of reverse causation and selection bias in epidemiologic studies of antibiotic use in early life and the development of asthma, we undertook a cohort study of this association in a complete population of children.
METHODS: Using the health-care and prescription databases of Manitoba, Canada, this longitudinal study assessed the association between antibiotic prescription use during the first year of life and asthma at age 7 years in a 1995 birth cohort of 13,116 children.
RESULTS: Independent of well-known asthma risk factors, asthma was significantly more likely to develop in children who had received antibiotics in the first year of life at age 7 years. The association with asthma was observed for antibiotic use in non-respiratory tract infections (adjusted odds ratio [OR], 1.86; 95% confidence interval [CI], 1.02 to 3.37). The risk of asthma was highest in children receiving more than four courses of antibiotics (adjusted OR, 1.46; 95% CI, 1.14 to 1.88), especially among rural children, and in the absence of maternal asthma or a dog in the birth year. Broad-spectrum (BS) cephalosporin use was more common in these subpopulations of children.
CONCLUSIONS: Antibiotic use in early life was associated with the development of childhood asthma, a risk that may be reduced by avoiding the use of BS cephalosporins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413050     DOI: 10.1378/chest.06-3008

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  89 in total

1.  Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase.

Authors:  K P Economopoulos; N L Ward; C D Phillips; A Teshager; P Patel; M M Mohamed; S Hakimian; S B Cox; R Ahmed; O Moaven; K Kaliannan; S N Alam; J F Haller; A M Goldstein; A K Bhan; M S Malo; R A Hodin
Journal:  Diabetes Obes Metab       Date:  2016-03-22       Impact factor: 6.577

2.  The human microbiome project.

Authors:  Peter J Turnbaugh; Ruth E Ley; Micah Hamady; Claire M Fraser-Liggett; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

3.  Does Helicobacter pylori protect against asthma and allergy?

Authors:  Martin J Blaser; Yu Chen; Joan Reibman
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

Review 4.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Authors:  Li Wen; Andrew Duffy
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

Review 5.  Environmental factors and eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2018-05-02       Impact factor: 10.793

Review 6.  Is asthma an infectious disease? New evidence.

Authors:  T Prescott Atkinson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

7.  Antibiotic exposure in early life and development of childhood asthma.

Authors:  Nikhil Dewan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-09       Impact factor: 3.275

Review 8.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

9.  Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases.

Authors:  A G Hirsch; J Pollak; T A Glass; M N Poulsen; L Bailey-Davis; J Mowery; B S Schwartz
Journal:  Clin Exp Allergy       Date:  2016-10-14       Impact factor: 5.018

10.  Infant antibiotic exposures and early-life body mass.

Authors:  L Trasande; J Blustein; M Liu; E Corwin; L M Cox; M J Blaser
Journal:  Int J Obes (Lond)       Date:  2012-08-21       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.